Autolus Therapeutics PLC (NAS:AUTL)
$ 3.92 0.05 (1.29%) Market Cap: 1.04 Bil Enterprise Value: 335.67 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Autolus Therapeutics plc - Special Call Transcript

Jun 25, 2020 / 12:30PM GMT
Release Date Price: $16.14 (+3.00%)
Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics AACR II Virtual Meeting Data Update. As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, Vice President, Head of Investor Relations. Please go ahead.

Lucinda Crabtree
Autolus Therapeutics plc - VP of IR & Corporate Communications

Thank you, Jill. Turning to Slide 2. Good morning or good afternoon, everyone, and thank you for taking part in today's call on the AACR II Virtual Meeting Data Update. I am Lucinda Crabtree, Vice President and Head of Investor Relations.

With me today are Dr. Christian Itin, our Chairman and Chief Executive Officer; Dr. Martin Pulé, our Founder and Chief Scientific Officer; Dr. Vijay Reddy, our Chief Medical Officer; Dr. Muhammad Al-Hajj, our Head of Translational Medicine; Dr. Marco Della Peruta, a senior scientist in the immunobiology department of our R&D team; Dr. Mathieu Ferrari, an Associate Director of Binders Discovery and our R&D team.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot